A1 Refereed original research article in a scientific journal
Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone
Authors: Gronlund J, Saari TI, Hagelberg NM, Neuvonen PJ, Olkkola KT, Laine K
Publisher: WILEY-BLACKWELL
Publication year: 2010
Journal: British Journal of Clinical Pharmacology
Journal name in source: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Journal acronym: BRIT J CLIN PHARMACO
Number in series: 1
Volume: 70
Issue: 1
First page : 78
Last page: 87
Number of pages: 10
ISSN: 0306-5251
DOI: https://doi.org/10.1111/j.1365-2125.2010.03653.x
Abstract
Drug interactions arising from CYP2D6 inhibition most likely have minor clinical importance for oral oxycodone if the function of the CYP3A4 pathway is normal. When both CYP2D6 and CYP3A4 pathways are inhibited, the exposure to oral oxycodone is increased substantially.
Drug interactions arising from CYP2D6 inhibition most likely have minor clinical importance for oral oxycodone if the function of the CYP3A4 pathway is normal. When both CYP2D6 and CYP3A4 pathways are inhibited, the exposure to oral oxycodone is increased substantially.